PMV Pharmaceuticals, Inc.

PMVP · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$36,337$44,127$51,341$40,876
Short-Term Investments$92,913$98,147$109,047$128,578
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,199$3,037$3,111$6,204
Total Curr. Assets$132,449$145,311$163,499$175,658
Property Plant & Equip (Net)$1,146$1,264$1,437$1,552
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$6,032$5,435$13,843
Tax Assets$0$0$0$0
Other NC Assets$249$248$237$235
Total NC Assets$1,395$7,544$7,109$15,630
Other Assets$0$0$0$0
Total Assets$133,844$152,855$170,608$191,288
Liabilities
Payables$3,399$2,598$3,593$6,579
Short-Term Debt$390$377$364$352
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8,515$8,632$5,802$7,439
Total Curr. Liab.$12,304$11,607$9,759$14,370
LT Debt$541$643$742$838
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$541$643$742$838
Other Liabilities$0$0$0$0
Cap. Leases$931$1,020$1,106$838
Total Liabilities$12,845$12,250$10,501$15,208
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$428,417-$407,358-$386,148-$368,712
AOCI$91$21$84$139
Other Equity$549,325$547,942$546,171$544,653
Total Equity$120,999$140,605$160,107$176,080
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$133,844$152,855$170,608$191,288
Net Debt-$35,406-$43,107-$50,235-$39,686